← back to search

Guo Ci Teo

National University Health System · US
Area of research
Spectroscopy · Molecular Biology
Research interest
Research interests include Advanced Proteomics Techniques and Applications, Mass Spectrometry Techniques and Applications, Metabolomics and Mass Spectrometry Studies, and Renal cell carcinoma treatment.
h-index
23
citations
5,031
works
35
NIH funding
primary concept
Biology
email

Recent publications

Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
Cancer Cell 2022cited by 202position: middledoi
Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors
Nature Biotechnology 2022cited by 116position: middledoi
MassIVE.quant: a community resource of quantitative mass spectrometry–based proteomics datasets
Nature Methods 2020cited by 137position: middledoi
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
Cell 2019cited by 767position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Alexey I. Nesvizhskii · Michigan Center for Translational Pathology2 papers (2020–2022)Jan Muntel · Biognosys (Switzerland)1 papers (2020–2020)Yasset Pérez‐Riverol · European Bioinformatics Institute1 papers (2020–2020)Merav D. Shmueli · Technical University of Munich1 papers (2022–2022) · 1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2022–2022)Ruth Hüttenhain · Stanford University1 papers (2020–2020)Nuno Bandeira · University of California San Diego1 papers (2020–2020)Olga Vitek · University of Michigan–Ann Arbor1 papers (2020–2020) · 1 papers (2022–2022) · 1 papers (2022–2022)Tomer Tsaban · Hebrew University of Jerusalem1 papers (2022–2022)Erik Verschueren · Gladstone Institutes1 papers (2020–2020)Ting Huang · East China University of Science and Technology1 papers (2020–2020) · 1 papers (2020–2020)Tom Dunkley · Newcastle University1 papers (2020–2020)David Morgenstern · Rush University Medical Center1 papers (2022–2022)Aaron Javitt · Princeton University1 papers (2022–2022)